The rising demand for improved aseptic handling, greater reproducibility and reduced errors have prompted the biopharmaceutical companies to consider shifting from manually operated sampling systems to automatic sampling systems
Roots Analysis is pleased to announce the publication of its recent study, titled, “Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA, 2022-2035” report to its list of offerings.
The report features an extensive study on the current and future potential of automatic sampling systems. Due to the growing demand for biologics and stringent regulatory guidelines, the biopharmaceutical industry has shifted to using automatic sampling methods, which offer reliable systems for transferring bioprocess samples directly from bioreactors to analytical devices while maintaining the process sterility and integrity. In addition, it features an elaborate discussion on the likely opportunity for the players engaged in this domain, over the next decade. Amongst other elements, the automatic sampling market report includes:
Key companies covered in the report
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/automatic-sampling-market.html
Learn from experts: do you know about these emerging industry trends?
Novel Antibody Therapies: Current Scenario and Future Potential
Manufacturing Execution Systems: A Step Towards Smart Manufacturing in Healthcare Sector
Explore more:
https://www.imkpoper.com/post/89708_patient-engagement-solutions-market-analysis-and-trends-by-2023-2035-patient-eng.html
https://anynote.co/read-blog/44221
https://www.ukwomenorg.com/read-blog/1470
https://www.snipesocial.co.uk/posts/317851
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415